People · Operator

Anthony E. Rosenberg

Named in public records as an officer, director or promoter · active 2011–2011 · Pharmaceuticals

1
Companies
1
Filings
$5.0M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Idenix Pharmaceuticals IncPharmaceuticalsSeries A$5.0M$154.9M2011
Operator network

Anthony E. Rosenberg at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

RONALD C. RENAUD JR. · 5 companies · 1 sharedRONALD C. RENAUD …Tamar D. Howson · 3 companies · 1 sharedTamar D. HowsonWayne T. Hockmeyer · 2 companies · 1 sharedWayne T. HockmeyerCharles W. Cramb · 1 companies · 1 sharedCharles W. CrambDaniella C. Beckman · 1 companies · 1 sharedDaniella C. Beckm…David N. Standring · 1 companies · 1 sharedDavid N. StandringDenise E. Pollard-Knight · 1 companies · 1 sharedDenise E. Pollard…Douglas J. Mayers · 1 companies · 1 sharedDouglas J. MayersMaria D. Stahl · 1 companies · 1 sharedMaria D. StahlPaul J. Fanning · 1 companies · 1 sharedPaul J. FanningRobert E. Pelzer · 1 companies · 1 sharedRobert E. PelzerThomas R. Hodgson · 1 companies · 1 sharedThomas R. HodgsonIdenix Pharmaceuticals Inc · $5.0M raisedIdenix Pharmaceutical…Anthony E. RosenbergAR
Anthony E. Rosenberg Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Anthony E. Rosenberg on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
RONALD C. RENAUD JR.15
Tamar D. Howson13
Wayne T. Hockmeyer12
Charles W. Cramb11
Thomas R. Hodgson11
Maria D. Stahl11
Paul J. Fanning11
Denise E. Pollard-Knight11
David N. Standring11
Daniella C. Beckman11
Douglas J. Mayers11
Robert E. Pelzer11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.